Aultra Pharmacy:

Search our Pharmacy Directory

Formulary:

Aultra Formulary for 2011
Aultra Formulary for 2011 - Numbered by Tier
Aultra Formulary for 2012
Aultra Formulary for 2012 - Numbered by Tier

Lipitor (Not a Recall)
The cholesterol-lowering medication, Lipitor (atorvastatin) will become available in generic form on November 28, 2011. AultCare will tier brand Lipitor at a Tier 1 generic co-payment from 11/28/11 through 5/31/12. The generic atorvastatin will be blocked for this time frame until additional manufacturers are able to market the medication. As of 6/1/12 Lipitor will be considered a Non-Preferred medication and generic substitution will be expected.

To aid the pharmacist in adjudication, the claims rejection response will contain a message reminding the pharmacist that they should dispense brand Lipitor.

If you have any questions, please contact us at 330-363-6360 or toll free at 1-800-344-8858 and request to speak to the Pharmacy Department.

Simvastatin 80mg Label Change (Not a Recall)
Following is information regarding label changes to Simvastatin 80mg. If you are currently on Simvastatin 80mg, DO NOT STOP TAKING YOUR MEDICATION without speaking to your physician first.

On 6/9/11 the FDA notified healthcare professionals that it is recommending limiting the use of the highest approved dose of the cholesterol-lowering medication simvastatin (80 mg) because of increased risk of muscle damage also known as myopathy. Simvastatin 80 mg should be used only in patients who have been taking this dose for 12 months or more without evidence of muscle injury (myopathy). Simvastatin 80 mg should not be started in new patients, including patients already taking lower doses of the drug.

Additional Information for Patients

Patients currently taking 80-mg simvastatin-containing medicines should:

• Not stop taking their medicine unless told to by their healthcare professional.
• Review their medical history with their healthcare professional, the currently prescribed dose of simvastatin, and a list of their other current medications to determine if the medicines they are taking are appropriate.
• Immediately contact their healthcare professional if they experience muscle pain, tenderness or weakness, dark or red colored urine, or unexplained tiredness.
• Talk to their healthcare professional about any questions or concerns they have about simvastatin-containing medicines.
• Report side effects from the use of simvastatin-containing medicines to the FDA MedWatch program using the following contact information:
  • Phone: 1-800-332-1088
  • Fax: 1-800-FDA-0178
  • MedWatch Online: https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm
  • Regular Mail: Use postage-paid FDA Form 3500.
    Mail to: MedWatch 5600 Fishers Lane, Rockville, MD 20857.

Drug Recalls

Medications that require Prior Authorization
• Growth Hormones
• Injectable Infertility medications
• Magnacet
• Oracea
• Solodyn
• Xolair and Synagis - if approved; this medication is covered under medical benefit not prescription benefit.

Certain medications may be covered under medical, require prior authorization and/or may have plan limitations. Please call the Aultra Service Center at 330-493-7278 or
1-800-325-8424, if you have questions or if you need a pharmacy listing.

Site Directory